Total revenues for the quarter ended at MNOK 109.8 (MNOK 82.5) and includes MNOK 5.3 granted by the U.S. Paycheck Protection Program related to COVID-19.
Total revenues for the first half ended at MNOK 212.4 (185.6). Operating profit (EBIT) for the quarter ended at MNOK 42.7 (MNOK 27.7), a 54.0% increase and by far the best EBIT for a quarter ever. Operating profit for the first half ended at MNOK 71.7 (MNOK 52.5), a 36.7% increase. This is also the best operating profit for the first half ever.
High growth in number of procedures in the USA with 50% – as well as consumable probe sales growth with 35% – reflect an increasing number of surgeries being performed and continuing recovery from the COVID pandemic.
See the full presentation and report below.